- Home
- GH vs FCPT Comparison
GH vs FCPT Comparison
Compare GH & FCPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- FCPT
- Stock Information
- Founded
- GH 2011
- FCPT 2015
- Country
- GH United States
- FCPT United States
- Employees
- GH N/A
- FCPT N/A
- Industry
- GH Medical Specialities
- FCPT Real Estate Investment Trusts
- Sector
- GH Health Care
- FCPT Real Estate
- Exchange
- GH Nasdaq
- FCPT Nasdaq
- Market Cap
- GH 2.7B
- FCPT 2.6B
- IPO Year
- GH 2018
- FCPT N/A
- Fundamental
- Price
- GH $30.98
- FCPT $29.14
- Analyst Decision
- GH Strong Buy
- FCPT Buy
- Analyst Count
- GH 15
- FCPT 5
- Target Price
- GH $39.93
- FCPT $30.50
- AVG Volume (30 Days)
- GH 2.2M
- FCPT 654.3K
- Earning Date
- GH 11-06-2024
- FCPT 10-30-2024
- Dividend Yield
- GH N/A
- FCPT 4.70%
- EPS Growth
- GH N/A
- FCPT N/A
- EPS
- GH N/A
- FCPT 1.07
- Revenue
- GH $692,256,000.00
- FCPT $264,880,000.00
- Revenue This Year
- GH $31.00
- FCPT N/A
- Revenue Next Year
- GH $17.55
- FCPT $7.11
- P/E Ratio
- GH N/A
- FCPT $27.46
- Revenue Growth
- GH 29.20
- FCPT 9.08
- 52 Week Low
- GH $15.81
- FCPT $22.38
- 52 Week High
- GH $37.04
- FCPT $30.93
- Technical
- Relative Strength Index (RSI)
- GH 70.13
- FCPT 61.54
- Support Level
- GH $28.45
- FCPT $28.56
- Resistance Level
- GH $32.26
- FCPT $29.13
- Average True Range (ATR)
- GH 1.70
- FCPT 0.55
- MACD
- GH 0.39
- FCPT 0.18
- Stochastic Oscillator
- GH 75.19
- FCPT 87.34
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About FCPT Four Corners Property Trust Inc.
Four Corners Property Trust Inc is a real estate investment trust predominantly engaged in the ownership, acquisition and leasing of restaurant and retail properties. The company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries. The firm operates through two segments namely, real estate operations and restaurant operations. The real estate operations segment consists of rental revenues generated by leasing restaurant and retail properties to tenants. The restaurant operations segment is conducted through a taxable REIT subsidiary (TRS) and consists of Kerrow Restaurant Operating Business. The firm generates majority of the revenue from the real estate operations segment.